CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +175 | 38,186 | ||
| 2025-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −85 | $38.49 | $3K | 38,101 |
| 2025-10-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −175 | 0 | ||
| 2025-09-29 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +42,000 | $17.92 | $753K | 76,552 |
| 2025-09-29 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −42,000 | $38.33 | $1.6M | 34,552 |
| 2025-09-29 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −42,000 | 0 | ||
| 2025-09-15 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +6,500 | $8.83 | $57K | 50,952 |
| 2025-09-15 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −16,044 | $36.45 | $585K | 34,908 |
| 2025-09-15 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −356 | $37.00 | $13K | 34,552 |
| 2025-09-15 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −6,500 | 19,000 | ||
| 2025-09-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +13,389 | $15.52 | $208K | 57,841 |
| 2025-09-05 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −13,389 | $35.66 | $477K | 44,452 |
| 2025-09-05 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −13,389 | 0 | ||
| 2025-09-04 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +38,725 | $15.50 | $600K | 83,177 |
| 2025-09-04 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +46,546 | $15.52 | $722K | 129,723 |
| 2025-09-04 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −85,271 | $35.52 | $3.0M | 44,452 |
| 2025-09-04 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −38,725 | 6,249 | ||
| 2025-09-04 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −46,546 | 13,389 | ||
| 2025-09-04 | Moat Ross CHIEF CORP. & COMM. OFFICER | Sale 10b5-1 | −3,523 | $35.31 | $124K | 9,415 |
| 2025-09-03 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +65 | $15.52 | $1K | 44,517 |
Page 22 of 74 · 1,467 trades